Hideaki Miyoshi Selected Research

Hideaki Miyoshi Research Topics

Disease

40	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2015
12	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 01/2016
10	Body Weight (Weight, Body) 04/2023 - 03/2017
9	Neoplasms (Cancer) 10/2023 - 01/2010
8	Autoimmune Pancreatitis 09/2019 - 07/2010
7	Atherosclerosis 02/2023 - 01/2015
7	Insulin Resistance 11/2022 - 12/2007
7	Pancreatitis 06/2021 - 03/2011
6	Hyperglycemia 10/2023 - 01/2015
5	Fatty Liver 07/2021 - 03/2017
5	Obesity 02/2021 - 05/2010
4	Pain (Aches) 11/2021 - 01/2008
4	Hypertension (High Blood Pressure) 10/2021 - 01/2016
4	Pituitary Neoplasms (Pituitary Adenoma) 04/2021 - 01/2019
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 01/2009
4	Immunoglobulin G4-Related Disease 02/2016 - 03/2011
4	Fibrosis (Cirrhosis) 12/2014 - 10/2011
4	Chronic Pancreatitis 01/2014 - 03/2011
3	Adenoma (Adenomas) 10/2023 - 01/2021
3	Atherosclerotic Plaque (Atheroma) 02/2023 - 01/2018
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2022 - 05/2013
3	Diabetes Mellitus 08/2021 - 07/2012
3	Fever (Fevers) 04/2021 - 01/2016
3	Dyslipidemias (Dyslipidemia) 02/2021 - 01/2018
3	Glucose Intolerance 01/2021 - 05/2010
3	Insulinoma 09/2018 - 01/2016
3	Autoimmune Diseases (Autoimmune Disease) 01/2012 - 03/2011
2	Hypertriglyceridemia 10/2022 - 09/2020
2	Hypophosphatemia 11/2021 - 09/2017
2	Pathologic Constriction (Stenosis) 06/2021 - 12/2020
2	Infections 04/2021 - 01/2021
2	Ketosis 02/2021 - 09/2019
2	Acromegaly 01/2021 - 01/2019
2	Cholangitis 12/2020 - 09/2014
2	Hyperinsulinism (Hyperinsulinemia) 07/2020 - 01/2016
2	Chronic Renal Insufficiency 01/2020 - 11/2019
2	Albuminuria 01/2020 - 01/2017
2	Hyponatremia 10/2019 - 01/2017
2	Disease Progression 10/2019 - 01/2019
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 10/2019 - 07/2014
2	Hypocalcemia 07/2019 - 09/2017

Drug/Important Bio-Agent (IBA)

32	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2015
16	Insulin (Novolin)FDA Link 04/2023 - 12/2007
10	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2022 - 01/2016
9	Immunoglobulin G (IgG)IBA 02/2016 - 07/2010
7	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2016
6	Hypoglycemic Agents (Hypoglycemics)IBA 04/2023 - 09/2018
6	Liraglutide FDA Link 01/2023 - 01/2015
6	SteroidsIBA 04/2022 - 03/2011
6	SodiumIBA 08/2021 - 06/2016
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2021 - 05/2013
5	ipragliflozinIBA 11/2019 - 06/2016
4	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2023 - 10/2019
4	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2023 - 10/2019
4	LipidsIBA 02/2023 - 10/2017
4	Immunoglobulins (Immunoglobulin)IBA 02/2016 - 07/2010
3	Hormones (Hormone)IBA 10/2023 - 04/2017
3	Messenger RNA (mRNA)IBA 10/2023 - 12/2007
3	Proteins (Proteins, Gene)FDA Link 02/2023 - 06/2011
3	dulaglutideIBA 01/2023 - 05/2019
3	semaglutideIBA 01/2023 - 03/2021
3	Metformin (Glucophage)FDA LinkGeneric 11/2022 - 01/2016
3	Sodium-Glucose Transport ProteinsIBA 05/2022 - 01/2020
3	IncretinsIBA 01/2022 - 01/2016
3	Triglycerides (Triacylglycerol)IBA 07/2021 - 01/2018
3	dapagliflozinIBA 07/2021 - 01/2017
3	oxidized low density lipoproteinIBA 01/2021 - 01/2018
3	NivolumabIBA 10/2019 - 01/2017
3	VildagliptinIBA 10/2017 - 08/2016
3	Sitagliptin Phosphate (Januvia)FDA Link 04/2017 - 01/2016
3	InterleukinsIBA 10/2011 - 12/2007
2	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2023 - 01/2015
2	Semaphorins (Semaphorin)IBA 01/2023 - 03/2021
2	AdiponectinIBA 01/2023 - 09/2018
2	insulin degludecIBA 01/2022 - 01/2016
2	AlbuminsIBA 01/2022 - 03/2019
2	Fibroblast Growth Factor-23IBA 11/2021 - 09/2017
2	Phosphates (Orthophosphate)IBA 11/2021 - 09/2017
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2018
2	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 10/2021 - 01/2020
2	CanagliflozinIBA 08/2021 - 01/2020
2	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 08/2021 - 01/2020
2	Pioglitazone (Actos)FDA Link 07/2021 - 01/2019
2	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2018
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2021 - 05/2019
2	Glucagon-Like Peptide-1 ReceptorIBA 03/2021 - 05/2019
2	C-PeptideIBA 01/2021 - 01/2018
2	ProinsulinIBA 07/2020 - 01/2020
2	AcidsIBA 06/2020 - 01/2015
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 09/2019 - 01/2017
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2019 - 01/2016
2	Everolimus FDA Link 09/2018 - 01/2018
2	Perilipin-1IBA 08/2018 - 05/2010
2	ApolipoproteinsIBA 08/2018 - 01/2018
2	SymportersIBA 01/2017 - 06/2016

Therapy/Procedure

22	Therapeutics 10/2022 - 01/2009
13	Glycemic Control 01/2023 - 01/2018
2	Stents 06/2021 - 12/2020
2	Self Expandable Metallic Stents 06/2021 - 12/2020